Enjoy complimentary customisation on priority with our Enterprise License!
The rapid microbiology testing market size is estimated to grow at a CAGR of 9.31% between 2022 and 2027. The size of the market is forecast to increase by USD 2,487.91 million. The growth of the market depends on several factors, including the increasing incidence of infectious diseases and cancer, the rise in the geriatric population, and the high prevalence of food-borne diseases.
This report extensively covers market segmentation by method (growth-based, nucleic-acid-based, viability-based, and others), end-user (hospitals and diagnostic laboratories, pharmaceutical and biotechnology companies, and others), and geography (North America, Asia, Europe, and Rest of World (ROW)). It also includes an in-depth analysis of drivers, trends, and challenges. Furthermore, the report includes historic market data from 2017 to 2021.
To learn more about this report, Download Rapid Microbiology Testing Market Research Report Sample PDF
The increasing incidence of infectious diseases and cancer is notably driving the market growth, although factors such as inadequate healthcare services in developing regions may impede the market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
The increasing incidence of infectious diseases and cancer is the key factor driving the global rapid microbiology testing market growth. The prevalence of infectious diseases such as tuberculosis, HIV, pneumonia, and malaria has increased. HIV attacks eventually destroy the immune system, resulting in AIDS, although this progression takes years. Thus, the body cannot defend itself against germs and infections as the immune system is compromised.
A compromised immune system makes the individual susceptible to diseases such as tuberculosis and pneumonia. There has been an increase in awareness programs related to infectious diseases such as HIV, cancer, tuberculosis, and pneumonia to encourage preventive healthcare or early diagnosis for improved treatment outcomes. With the global burden of these diseases increasing, the demand for rapid microbiology techniques for faster and more accurate microbial screening, identification, and testing against pathogens is expected to grow significantly during the forecast period.
The rise in food safety concerns is the primary trend in the global rapid microbiology testing market. Individual food products are made up of plants and animals, and they usually contain a variety of microorganisms. Microbes from natural sources may come into contact with and contaminate food during manufacturing and consumption processes. Furthermore, microbial contamination of food items causes spoilage, which can result in foodborne illnesses if consumed. Foodborne illnesses are regarded as serious public health issues around the world.
The importance of food safety as a measure to prevent the spread of diseases is growing. In many countries, the government is significantly focusing on food-related safety standards. Regulatory authorities are constantly updating food safety regulations to ensure that the food and beverage industries deliver the optimum safety and quality of food products to consumers. Thus, the global rapid microbiology testing market report is expected to grow during the forecast period.
The inadequate healthcare services in developing regions is a major challenge to the global rapid microbiology testing market growth. Many people in developing regions such as APAC and MEA do not have the required knowledge or access to healthcare facilities to stay healthy. Also, the lack of financial resources is a major obstacle to public health, leading to an increase in infectious diseases, which is a significant public health concern. Moreover, healthcare systems in most developing countries are plagued by a lack of skilled personnel, making it difficult for them to provide access to quality healthcare services such as rapid microbiology testing.
The stigma or misconception about the gravity of conditions such as STDs further discourages any form of testing, including microbial testing and the subsequent treatment of infectious diseases. Hence, the drawbacks of developing countries, such as the prevalence of infectious diseases causing high mortality and morbidity, lack of skilled healthcare personnel and financial resources, and inadequate infrastructure and healthcare systems that are responsive to the needs of society, will hinder the growth of the market during the forecast period.
The rapid microbiology testing market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Global Rapid Microbiology Testing Market Customer Landscape
Vendors are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
abbott.com - The company offers solutions for rapid microbiology testing that includes a wide range of BACT/ALERT 3D culture media bottles adapted to the type of microbial detection performed.
The market report also includes detailed analyses of the competitive landscape of the market and information about 15 market vendors, including:
Qualitative and quantitative analysis of vendors has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak.
The market share growth of the growth-based segment will be significant during the forecast period. Growth-based rapid microbiological testing differs from traditional culture methods in that it relies on the detection of biochemical or physiological growth indicators rather than visible growth. This generally allows for much faster detection, but it frequently necessitates a brief enrichment stage before microorganisms can be detected, especially in samples with low levels of contamination.
Get a glance at the market contribution of various segments Request Market Research Report Sample PDF
The growth-based segment was valued at USD 1,492.53 million in 2017 and continued to grow until 2021. Growth-based microbiology testing can provide a quantitative cell count, an estimation of viable cell concentration, information about the presence of a specific microorganism, or microbial identification. The growth-based microbiology testing segment holds the largest market share in the market due to an increase in the early detection of infectious diseases, and it will continue to dominate the market during the forecast period.
For more insights on the market share of various regions Request Market Research Report Sample PDF
North America is projected to hold a 41% share of the market in 2023. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
North America was the largest revenue contributor to the global rapid microbiology testing market in 2022, with the US being the leading country. The growing focus on drug and vaccine discovery and development, recent advances in biotechnology and pharmaceutical research, and the presence of several vendors in the country offering a wide range of microbial testing products are aiding the growth of the market. Therefore, the increase in emphasis on the production of drugs has played a major role in the adoption of microbial testing in the region.
In 2021, business and industrial activities resumed with the lifting of stringent lockdown restrictions due to the availability of COVID-19 vaccines and the vaccination drives carried out by the governments of different countries, such as the US, Canada, and Mexico. This has resulted in the resumption of rapid microbiology testing with proper safety and precautions in clinics and hospitals, which has further increased the demand for microbiology testing. The rise in various diseases among the population, such as bacterial infection, has been a major factor in the market's growth and expansion. Such elements will fuel the growth of the regional market during the forecast period.
The report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027. The market has been segmented by method, end-user, and region.
|
Rapid Microbiology Testing Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
156 |
|
Base year |
2022 |
|
Historic period |
2017-2021 |
|
Forecast period |
2023-2027 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 9.31% |
|
Market growth 2023-2027 |
USD 2,487.91 million |
|
Market structure |
Fragmented |
|
YoY growth (%) |
9.07 |
|
Regional analysis |
North America, Asia, Europe, and Rest of World (ROW) |
|
Performing market contribution |
North America at 41% |
|
Key countries |
US, Canada, Germany, UK, and China |
|
Competitive landscape |
Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks |
|
Key companies profiled |
Abbott Laboratories, Becton Dickinson and Co., bioMerieux SA, Biosensia Ltd., Bruker Corp., Charles River Laboratories, Colifast AS, Danaher Corp., Don Whitley Scientific Ltd., Euroclone SpA, Gradientech AB, Merck KGaA, Neogen Corp., Quidel Corp., Rapid Micro Biosystems Inc., rqMicro AG, Sartorius AG, Serosep Ltd., Solus Scientific Ltd., and Thermo Fisher Scientific Inc. |
|
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period. |
|
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Request Market Research Report Sample PDF
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Method
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
Secondary sources
DATA ANALYSIS
Data Synthesis
Data Validation
REPORT WRITING
Qualitative
Quantitative
Certified ISO 9001 : 2015
We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.
We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.
Get lifetime access to our
Technavio Insights
Customized Report as per your Business Needs
Let us help you make report more suited to your requirements.
Get the report (PDF) sent to your email within minutes.
